Phase 3 Tuberculosis Trial, Recruiting (NCT06719193)

Phase 3 Tuberculosis Trial, Recruiting NCT06719193 Sponsor: Management Sciences for Health Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT06719193 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who give their own consent to take part
Adults who live within the designated study area (woreda)
Young people aged 12 to 17 who agree to take part and whose guardian also gives consent on their behalf
Young people aged 12 to 17 who live within the designated study area (woreda)
Children under 12 years old whose guardian provides consent for them to take part
Children under 12 years old who live within the designated study area (woreda)

Who may not be able to join:

Adults who do not give their own consent, are under 18, or live outside the designated study area
Adults who are unwilling to share their contact information or who do not agree to be contacted by phone or in person if a study visit is missed
Young people aged 12 to 17 who do not agree to take part, whose guardian does not give consent, or who live outside the designated study area
Young people aged 12 to 17 whose guardian is unwilling to share contact information or does not agree to be contacted by phone or in person if a study visit is missed
Children under 12 whose guardian does not give consent, is unwilling to share contact information, or does not agree to be contacted by phone or in person if a study visit is missed
Children who are 12 or older are not eligible under the younger children category

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 617-250-9500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06719193

Sponsor: Management Sciences for Health

Phase: Phase 3

Status: Recruiting

Condition: Tuberculosis

Trial contact: 617-250-9500

More information: https://clinicaltrials.gov/study/NCT06719193

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who give their own consent to take part
Adults who live within the designated study area (woreda)
Young people aged 12 to 17 who agree to take part and whose guardian also gives consent on their behalf
Young people aged 12 to 17 who live within the designated study area (woreda)
Children under 12 years old whose guardian provides consent for them to take part
Children under 12 years old who live within the designated study area (woreda)

Who may not be able to join:

Adults who do not give their own consent, are under 18, or live outside the designated study area
Adults who are unwilling to share their contact information or who do not agree to be contacted by phone or in person if a study visit is missed
Young people aged 12 to 17 who do not agree to take part, whose guardian does not give consent, or who live outside the designated study area
Young people aged 12 to 17 whose guardian is unwilling to share contact information or does not agree to be contacted by phone or in person if a study visit is missed
Children under 12 whose guardian does not give consent, is unwilling to share contact information, or does not agree to be contacted by phone or in person if a study visit is missed
Children who are 12 or older are not eligible under the younger children category

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Management Sciences for Health

Registry

ClinicalTrials.gov

Start date

27 February 2023

Est. completion

1 January 2025

Where this trial is recruiting

Ethiopia

Primary endpoints

Population-level TB prevalence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov